Patent Protection Until 2041 Awarded for Transdermal Creams Formulated with CBD and THC
VANCOUVER, BC and LAS VEGAS, Sept. 14, 2022 /CNW/ - (CSE: OVAT) (OTC-BB:OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted Ovation a patent entitled "Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and 9-Tetrahydrocannabinol (THC)"; (US Patent Number: 11,439,602), with an expiry of February 2041.
Read more at newswire.ca